XML 35 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation - Additional Information (Detail) (USD $)
12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2011
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Options granted and outstanding to purchase 3,419,285 1,910,794 729,096
Number of Options Outstanding, Granted 1,509,166 1,229,500  
Options granted outside of Equity Incentive plans 50,000    
Stock-based compensation expense $ 1,536,271 $ 1,241,404  
Fair value of the options granted 2,843,575 4,091,117  
Intrinsic value of the options exercised 554 0  
Dividend yield 0.00%    
Calando Pharmaceuticals Inc
     
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Fair value of the options granted   33,690  
Pre-tax compensation expense 32,952    
Weighted average period to recognize pre-tax compensation expense 2 years 3 months 18 days    
Arrowhead
     
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Pre-tax compensation expense $ 5,072,252    
Weighted average period to recognize pre-tax compensation expense 3 years 1 month 6 days    
2000 Stock Option Plan
     
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Shares reserve for issuance 153,200    
Options granted and outstanding to purchase 152,900    
2004 Equity Incentive Plan
     
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Shares reserve for issuance 2,965,185    
Options granted and outstanding to purchase 2,965,185    
Number of Options Outstanding, Granted 1,459,166